March 8, 2018

Innate Pharma's management team will host a R&D Day on March 8, 2018, in London.

This event will highlight Innate’s leading scientific role in immuno-oncology and its emerging proprietary portfolio, provide a more in-depth look at lead projects, IPH4102 and IPH5401, and their commercial potential.

The event is intended for institutional investors and sell-side analysts only.